New Ebola vaccine enters clinical trials in Africa as DR Congo battles outbreak
Phase Ib trials for ChAdOx1 vaccine, developed by University of Oxford, began in Uganda on Oct. 6, official says
Read original article on Anadolu Ajansı Güncel Haberler →